Cargando…
A Physiologically Based Pharmacokinetic Framework for Quantifying Antibody Distribution Gradients from Tumors to Tumor-Draining Lymph Nodes
Immune checkpoint blockades prescribed in the neoadjuvant setting are now under active investigation for many types of tumors, and many have shown early success. The primary tumor (PT) and tumor-draining lymph node (TDLN) immune factors, along with adequate therapeutic antibody distributions to the...
Autores principales: | Salgado, Eric, Cao, Yanguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036243/ https://www.ncbi.nlm.nih.gov/pubmed/35466281 http://dx.doi.org/10.3390/antib11020028 |
Ejemplares similares
-
Unlocking the therapeutic potential of primary tumor-draining lymph nodes
por: Rotman, Jossie, et al.
Publicado: (2019) -
Immune Checkpoint Therapy: Tumor Draining Lymph Nodes in the Spotlights
por: Fransen, Marieke F., et al.
Publicado: (2021) -
Chemotherapy but Not the Tumor Draining Lymph Nodes Determine the Immunotherapy Response in Secondary Tumors
por: Zhao, Xianda, et al.
Publicado: (2020) -
Mechanisms of Tumor-Induced Lymphovascular Niche Formation in Draining Lymph Nodes
por: Commerford, Catharina D., et al.
Publicado: (2018) -
Tumor-Draining Lymph Secretome En Route to the Regional Lymph Node in Breast Cancer Metastasis
por: Mohammed, Sulma I, et al.
Publicado: (2020)